1.Low Grade Chondrosarcoma Presenting as Progressive Valgus Limb Deformity in a Growing Period.
Hyun Guy KANG ; Weon Seo PARK ; Seog Yun PARK
The Journal of the Korean Bone and Joint Tumor Society 2014;20(1):41-45
A femoral bone tumor causing a valgus deformity by affecting the growth plate was found. Long intramedullary diaphyseal tumor was separated by septum at the metapysis. Low grade chondrosarcoma was confirmed diagnosed by pathologists. Progressive limb deformity can be a sign of bone tumor in growing period.
Chondrosarcoma*
;
Congenital Abnormalities*
;
Extremities*
;
Growth Plate
2.Ovarian mature cystic teratoma with histologic features of chronic thyroiditis: Histologic analysis of 4 cases.
Doo Hyun CHUNG ; Weon Seo PARK ; Soo Min KANG ; Eun Sil YU ; Seong Hoe PARK
Korean Journal of Pathology 1992;26(3):209-214
We have reviewed ovarian mature cystic teratomas with features of chronic thyroiditis that were diagnosed at the department of pathology, Seoul National University Hospital during 7 years, 1984-1991. Twenty three case(8%) containing thyroid tissue among 285 ovarian mature teratomas were available for histopathologic examination. Among these, 4 cases(1.4%) showed lymphocytic infiltration with lymphoid follicle formation. These four cases were examined according to the strict histologic criteria of autoimmune thyroiditis and reactive non-autoimmune thyroiditis for the purpose of differentiation of pathogenesis. Two cases were similar to autoimmune in nature and the other two cases simply seemed to reflect reactive features to adjacent stimulating elements. In conclusion, thyroid tissue present in ovarian cystic teratoma may have histologic features of chronic thyroiditis of either autoimmune or non-autoimmune origin.
3.Squamous Metaplasia in Tubular Adenoma of Sigmoid Colon: A case report.
Soo Min KANG ; Weon Seo PARK ; Woo Ho KIM ; Yong Il KIM
Korean Journal of Pathology 1993;27(6):663-665
The occurrence of squamous metaplasia(morule) in colorectal mucosa and adenocarcinoma, althrough rare, has been well documented. In contrast, very little mention has been given to mature squamous cells seen in colorectal polyps or adenomas. A 42-year-old woman presented with a 2-month history of diarrhea and melena. Proctosigmoidoscopy revealed a 4 cm-sized polypoid tumor 20 cm above the anal verge. Colonoscopic biopsy showed tubular adenoma, and a segmental resection of sigmoid colon was done. Microscopically, the tumor was c classical tubular adenoma containing multiple solid nests of squamous cells scattered only in the neoplasm; the squamous nests were generally small, and some showed direct continuity with adenomatous glands. The squamous cells were keratinizing and had regular nuclei with no mitotic activity. The importance of this phenomenon lies in its pathologic recognition, and the findings suggest that awareness of this rare occurrence in colorectal polyps should avert such overdiagnosis, and consequently prevents unnecessary radical surgery.
Female
;
Humans
;
Adenoma
;
Biopsy
4.SCC-Ag As A Significant Prognostic Indicator in Recurrent Cervical Cancer.
Soon Beom KANG ; Chul Min LEE ; Su Young OH ; Ju Weon ROH ; Yong Beom KIM ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 1999;42(9):1955-1964
OBJECTIVE: This study was performed to identify the prognostic factor for survival of patients with recurrent cervical cancer. METHODS: Sixty-eight patients were diagnosed as recurrent cervical cancer at the Seoul National University Hospital from January, 1988 to December, 1998. Recurrence was defined as new evidence of tumor after 6 months of disease free survival. Retrospective analysis was done in terms of clinical features and the Cox proportional hazard model was used to identify independent variables associated with an improved survival rate. Histopathologic types were distributed as follows; squamous cell carcinoma in 70.6%, adenocarcinoma in 11.8%, adenosquamous cell carcinoma in 11.8%, and small cell carcinoma in 1.5%. Distribution of FIGO stage was as follows; stage I in 25.0%, stage II in 66.2%, and stage III in 4.4%. Sites of recurrence were as follows; central pelvic recurrence in 44.1%, pelvic side wall recurrence in 11.8%, and distant metastasis in 44.1% and the most common site of distant recurrence was extrapelvic lymph nodes (29.4%). 29.4% of recurrences were observed within the first 12 months after initial therapy, 50.0% within 2 years and 64.7% within 3 years. RESULTS: Positive rate of SCC-Ag at initial diagnosis was 45.2% with cutoff value of 2.0 ng/ml. Positive rate of SCC-Ag at the diagnosis of recurrence was 60.0%. Overall response rate to the treatment was 29.1%. Complete response rate was higher in central pelvic recurrrence than pelvic side wall recurrence and distant metastasis (P = 0.002) and also higher in normal SCC-Ag level (< or = 2.0 ng/ml) at the diagnosis of recurrence than elevated level (P = 0.032). Cumulative survival rates of 1 year after recurrence was 66.8%, 2 year 36.7%, and 5 year 18.7%. Central recurrence showed higher cumulative survival rate than pelvic side wall or distant recurrence (P = 0.029). The patients with elevated SCC-Ag level at the time of diagnosis of recurrence showed lower cumulative survival rate than those with normal SCC-Ag level (P < 0.001). Cox proportional hazard model showed that SCC-Ag elevation at the time of diagnosis of recurrence retained significant values in predicting survival(OR = 2.56; 95% CI = [1.22-5.39]; P = 0.01). CONCLUSION: SCC-Ag elevation at the diagnosis of the recurrence is a strong independent prognostic indicator for survival of patients with recurrent cervical cancer.
Adenocarcinoma
;
Carcinoma, Small Cell
;
Carcinoma, Squamous Cell
;
Diagnosis
;
Disease-Free Survival
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Proportional Hazards Models
;
Recurrence
;
Retrospective Studies
;
Seoul
;
Survival Rate
;
Uterine Cervical Neoplasms*
5.Esophagus, Stomach & Intestine; Evaluation of Endoscopic Ultrasonography in Gastric Carcinoma.
Hong Bae PARK ; Hyang Soon YEO ; Myung Weon KANG ; Ki Chang OH ; Jang Hyun CHO ; Hyung Chul CHO ; Jin Ho CHU ; Weon Seuk KIM ; Myung Won KIM
Korean Journal of Gastrointestinal Endoscopy 1997;17(1):8-14
BACKGROUND: Endoscopic Ultrasonography(EUS), a combination of endoscopy and ultrasonography is one of the most useful tools for diagnosis of digestive system diseases. EUS is useful in staging the primary tumor invasion and regional lymph node metastasis because of its ability to image the gut wall and adjacent structures in unique detail. We performed a study preoperatively for assessing the accuracy and limitation of EUS in gastric carcinoma. METHODS: In 75 patients(Male 54, Female 21, Mean age 62.3 years) with a gastric carcinoma confirmed by endoscopic biopsy, we performed EUS preoperatively. The results were compared with the postoperative histopathologic staging. RESULTS: 1) In assessing the depth of tumor invasion, EUS accuracy on depth of invasion was 76.0% and overstaging and understaging were 14.7% and 9.3%, respectively. 2) In assessing the lymph node metastasis, the accuracy rate of EUS was 65.3%. A rate of false-positive diagnosis was 27.3%, and a rate of false-negative diagnosis was 24.5%.3) In assessing the incidence of lymph node metastasis for each T stage, the involve rate was 10.5% in pT1, 36.4% in pT2, 95.7% in pT3, 100% in pT4. CONCLUSIONS: EUS is the most accurate diagnostic methods presently available to determine tumor infiltration depth and lymph node metastasis.
Biopsy
;
Diagnosis
;
Digestive System Diseases
;
Endoscopy
;
Endosonography*
;
Esophagus*
;
Female
;
Humans
;
Incidence
;
Intestines*
;
Lymph Nodes
;
Neoplasm Metastasis
;
Stomach*
;
Ultrasonography
6.A Case of Complete Response in Locally Advanced Vulvar Cancer after Concomitant Chemoradiation Therapy.
Soo Yeon HAN ; Noh Hyun PARK ; Hong Gyun WU ; Ju Weon ROH ; Hyeon Jeong JEONG ; Jae Weon KIM ; Yong Sang SONG ; Soon Beom KANG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 1999;42(9):2126-2131
Cancer of the vulva accounts for approximately 0.5% of all gynecologic malignancies. At diagnosis, one-third of these cases is detected in an advanced stage (FIGO stages III, IV), and local extension of primary vulvar cancer may involve adjacent midline structures such as the clitoris, urethra, vagina, and anus. Initial surgical therapy of such locally advanced primary cancers may compromise the functional integrity of midline structures, necessitating ultraradical surgery including pelvic exenteration. In view of the relatively elderly age of the patients and the morbidity of this ultraradical dissection, concomitant chemoradiation therapy - that the efficacy had been proven in head and neck cancer, anal cancer has approached for patients with locally advanced vulvar cancer. We experienced a case of stage III vulvar cancer patient, who underwent concomitant chemoradiation therapy with 5-fluorouracil(FU) and cisplatin and who showed complete response. So, we report this case with brief review of the literatures.
Aged
;
Anal Canal
;
Anus Neoplasms
;
Cisplatin
;
Clitoris
;
Diagnosis
;
Female
;
Head and Neck Neoplasms
;
Humans
;
Pelvic Exenteration
;
Urethra
;
Vagina
;
Vulvar Neoplasms*
7.Clinical Efficacy of Ifosfamide-Based Regimen in Refractory of Relapsed Ovarian Cancer.
Hyo Pyo LEE ; Noh Hyun PARK ; Jae Weon KIM ; Seo Young PARK ; Yong Sang SONG ; Soon Beom KANG
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(4):263-269
This phase II study aimed to assess the clinical activity and toxicity of ifosfamide based regimen in patients with epithelial ovarian cancer, relapsed or refractory to cisplatin-containing combination chemotherapy. From July 1991 to June 1993, 18 patients with epithelial ovarian cancer, relapsed or refractory to cisplatin were treated as follows. Relapsed cases were treated with IP(ifosfamide 4,0g/m2 intravenously and cisplatin 60mg/m2 intravenously on day 1) regimen every 3-4 weeks. The regimen used in refractory cases was Et-I(etoposide 100mg/m2 intravenously on days 1 to 3 and ifosfamide 1.0g/m2 intravenously on days 1 to 5) regimen every 3 or 4 weeks. The uroprotectant mesna was concomitantly used. Responses and toxicities were evaluated according to the WHO Criteria. The overall response rate was 27.8%(5/18), including 2 complete response and 3 partial response. There were four episodes(22.2%) of grade 3, 4 myelosuppression, but no other grade 3, 4 non-hematologic toxicity. Salvage therapy with ifosfamide based regimen is a useful and well tolerated treatment strategy in selected patients with relapsed ovarian cancer.
Cisplatin
;
Drug Therapy, Combination
;
Humans
;
Ifosfamide
;
Mesna
;
Ovarian Neoplasms*
;
Recurrence
;
Salvage Therapy
8.Clinical review about corrective surgery of tetralogy of Fallot.
Kwang Hyun CHO ; Youn Ho WHANG ; Yang Haeng LEE ; Jong Weon PARK ; Shin Hyun JUNG ; Kang Joo CHOI
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(7):674-684
No abstract available.
Tetralogy of Fallot*
9.Open heart surgery 600 cases for 5 years.
Kwang Hyun CHO ; Yoon Ho WHANG ; Yang Haeng LEE ; Jong Weon PARK ; Sin Hyun JUNG ; Kang Ju CHOI
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(4):404-420
No abstract available.
Heart*
;
Thoracic Surgery*
10.Geographical Variations in the Incidence of Childhood Cancer.
Duk Hee LEE ; Hai Rim SHIN ; Kang Weon PARK ; Yoon Ok AHN
Journal of the Korean Cancer Association 1998;30(3):425-434
PURPOSE: The incidence of childhood cancer in the Korea was studied to compare incidence rates between countries and between different regions in Korea. MATERIALS AND METHODS: A tatal of 2,891 cases, registered in the Natinal Cancer Registy from 1993 to 1995, were analysied. Death Certificate Only(DCO) cases were not included. DCO % was estimated about 22%. We calculated the incidence rates according to the International Classification of Childhood Cancer. The age-standardized rates by diagnostic group was compared with those of other countries. The total incidence of childhood cancer were compared among 34 cities in Korea with the rates in the rest of the nation. RESULTS: The crude incidence of all childhood cancer was 94.1 per million. The cumulative incidence to age 15 was 0.137% and the age-standardized rate, calculated using the world standard population, was 96.1 per million. In the incidence rates by diagnostic group, we observed many similarities with other countries in East Asia. The age-standardized rates of E, F and AL cities were significantly higher(p<0.05). In the 0-4 age group, F, AL and BB cities showed higher rates(p<0.05). In 5~9 years and 10~14 years, F city only had higher rates(p<0.05). CONCLUSION: Further study will be needed in order to investigate possible environmental factors which may account for the regional variations.
Classification
;
Death Certificates
;
Far East
;
Humans
;
Incidence*
;
Korea